獸用濾泡刺激素(FSH) 市場規模、佔有率和成長分析：按產品類型、動物種類、最終用戶、給藥途徑和地區分類－2026-2033 年產業預測

2024 年全球獸用濾泡刺激素(FSH) 市場價值為 1.5 億美元，預計到 2033 年將從 2025 年的 1.6275 億美元成長至 3.1258 億美元，預測期（2026-2033 年）的複合年成長率為 8.5%。

全球獸用濾泡刺激素(FSH) 市場的主要驅動力是不斷成長的畜牧業繁殖效率提升需求。生產者利用 FSH 來促進高排卵、同步發情，並輔助胚胎移植和體外受精 (IVF)。該市場涵蓋純化的腦下垂體萃取物和重組 FSH 產品，適用於牛、豬、羊和山羊。繁殖能力的提升可提高畜群生產力，並有助於保障糧食安全。向標準化重組製劑的轉變，加上有效的法規結構和生產成本的降低，正在推動市場成長，尤其是在新興經濟體。此外，人工智慧的進步透過使荷爾蒙生產與繁殖週期和需求模式相匹配，最佳化了生產預測並提高了效率，同時也有助於改善資源管理並減少供應鏈中的廢棄物。

全球獸用濾泡刺激素（FSH）市場成長要素

全球獸醫領域對濾泡刺激素(FSH) 的需求主要源自於養殖戶輔助生殖技術的日益普及以及有效畜群管理策略的實施。獸醫和畜牧養殖戶擴大將 FSH 納入育種計劃，以改善繁殖管理並最佳化配種方案。 FSH 可促進可控性高排卵，提高繁殖週期的可預測性，從而有助於胚胎移植和遺傳選擇計劃的製定。這項進展減少了季節性繁殖的限制，並實現了更有針對性的畜群改良，因此，尋求確保繁殖成功和遺傳改良的商業養殖戶越來越接受荷爾蒙療法。

全球獸用濾泡刺激素（FSH）市場的限制因素

獸用荷爾蒙產品供應鏈面臨的挑戰，例如某些地區低溫運輸基礎設施不足和分銷網路分散等，會阻礙濾泡刺激素（FSH）產品可靠地供應給動物醫院和農場。依賴專業物流和本地分銷商往往會導致存量基準波動和延遲，這可能會阻礙獸醫將FSH納入常規診療流程。這些可得性問題增加了獸醫感知到的營運風險，並削弱了考慮採用荷爾蒙療法的生產者的信心。因此，這種情況阻礙了市場擴張，並限制了在不同的農業環境中採用統一的育種管理通訊協定。

全球獸用濾泡刺激素（FSH）市場趨勢

全球獸用濾泡刺激素(FSH) 市場正經歷顯著成長，主要得益於先進繁殖管理策略的日益普及。這種轉變推動了對客製化 FSH 產品的需求，這些產品不僅要滿足個別動物的獨特需求，還要兼顧群體層面的管理。透過整合診斷資訊、健康記錄系統和目標明確的育種計劃，獸醫能夠最佳化給藥時間和劑量，最大限度地減少治療差異，同時改善繁殖效果。此外，服務型產品、專業訓練課程和決策支援工具的出現，增強了獸醫的信心，並鼓勵生產者採用這些先進的解決方案。因此，動物福利和營運效率在商業動物和特種動物領域都變得日益重要。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球獸用濾泡刺激素(FSH) 市場規模：依產品類型分類

• 天然卵泡刺激素
• 合成FSH

全球獸用濾泡刺激素(FSH) 市場規模：依動物類型分類

• 家畜
  • 牛
  • 豬
• 伴侶動物
  • 狗
  • 貓
  • 其他

全球獸用濾泡刺激素(FSH) 市場規模：依最終用戶分類

• 動物診所
• 研究所
• 製藥公司

全球獸用濾泡刺激素(FSH) 市場規模：依給藥途徑分類

• 注射藥物
• 口服

全球獸用濾泡刺激素(FSH) 市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• Zoetis
• Merck Animal Health
• Elanco Animal Health
• Boehringer Ingelheim
• Cegelec
• Neogen Corporation
• Vetoquinol
• Bayer Animal Health
• Virbac
• Dechra Pharmaceuticals
• IDEXX Laboratories
• Phibro Animal Health
• Parnell
• Kemin Industries
• Stryker Corporation
• Agrekko
• Intas Pharmaceuticals
• Bayer CropScience
• Trivium Veterinary Solutions
• Market Player 20

結論與建議

Global Veterinary Follicle Stimulating Hormones (Fsh) Market size was valued at USD 150.0 Million in 2024 and is poised to grow from USD 162.75 Million in 2025 to USD 312.58 Million by 2033, growing at a CAGR of 8.5% during the forecast period (2026-2033).

The global veterinary follicle stimulating hormone (FSH) market is driven mainly by the increasing need for reproductive efficiency in livestock, as producers leverage FSH to enhance superovulation, synchronize estrus, and facilitate embryo transfer and IVF. The market includes both purified pituitary extracts and recombinant FSH products utilized in cattle, swine, sheep, and goats. Improved fertility translates into greater herd productivity and supports food security. The shift towards standardized recombinant formulations, combined with effective regulatory frameworks and reduced production costs, has stimulated the market's growth, especially in emerging economies. Additionally, advancements in AI are optimizing production forecasting-enhancing efficiency by aligning hormone production with breeding cycles and demand patterns, while enabling better resource management and reducing waste in the supply chain.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Follicle Stimulating Hormones (Fsh) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Follicle Stimulating Hormones (Fsh) Market Segments Analysis

Global veterinary follicle stimulating hormones (fsh) market is segmented by product type, animal type, end user, administration route and region. Based on product type, the market is segmented into Natural FSH and Synthetic FSH. Based on animal type, the market is segmented into Livestock and Companion Animals. Based on end user, the market is segmented into Veterinary Clinics, Research Laboratories and Pharmaceutical Companies. Based on administration route, the market is segmented into Injectable and Oral. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary Follicle Stimulating Hormones (Fsh) Market

The global demand for follicle stimulating hormones (FSH) in veterinary practice is being significantly driven by the increasing adoption of assisted reproductive techniques and effective herd management strategies by farmers. Veterinarians and breeders are increasingly incorporating FSH into their breeding programs to improve fertility management and optimize reproductive scheduling. By facilitating controlled superovulation and enhancing the predictability of breeding cycles, FSH enables better planning for embryo transfers and genetic selection programs. This advancement diminishes the constraints of seasonal breeding and allows for more focused herd improvement efforts, fostering greater acceptance of hormonal treatments among commercial producers aiming for reliable reproductive success and genetic advancement.

Restraints in the Global Veterinary Follicle Stimulating Hormones (Fsh) Market

Challenges within the veterinary hormone supply chain, such as inadequate cold chain infrastructure in certain areas and disjointed distribution networks, can hinder the reliable availability of follicle stimulating hormone (FSH) products for veterinary clinics and farms. The dependence on specialized logistics and regional distributors often results in delays and fluctuating stock levels, which may discourage veterinarians from incorporating FSH into their standard practices. These accessibility issues elevate perceived operational risks for practitioners and diminish the confidence of breeders contemplating hormonal treatments. Consequently, this situation impairs market expansion and restricts the adoption of uniform reproductive management protocols in various agricultural environments.

Market Trends of the Global Veterinary Follicle Stimulating Hormones (Fsh) Market

The Global Veterinary Follicle Stimulating Hormones (FSH) market is experiencing a significant upward trend propelled by the increasing adoption of precision reproductive management strategies. This shift is fostering a demand for tailored FSH products that cater to the unique needs of individual animals, as well as herd-level approaches. Enhanced integration of diagnostic information, health record systems, and targeted breeding plans is allowing veterinarians to optimize timing and dosage, thus improving fertility outcomes while minimizing treatment inconsistencies. Moreover, the rise of service-oriented offerings, professional training programs, and decision-support tools is bolstering practitioner confidence and encouraging producers to adopt these advanced solutions, ultimately emphasizing animal welfare and operational efficiency in both commercial and specialty animal sectors.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Veterinary Follicle Stimulating Hormones (FSH) Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Natural FSH
• Synthetic FSH

Global Veterinary Follicle Stimulating Hormones (FSH) Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Livestock
  • Cattle
  • Swine
• Companion Animals
  • Dogs
  • Cats
  • Others

Global Veterinary Follicle Stimulating Hormones (FSH) Market Size by End User & CAGR (2026-2033)

• Market Overview
• Veterinary Clinics
• Research Laboratories
• Pharmaceutical Companies

Global Veterinary Follicle Stimulating Hormones (FSH) Market Size by Administration Route & CAGR (2026-2033)

• Market Overview
• Injectable
• Oral

Global Veterinary Follicle Stimulating Hormones (FSH) Market Size & CAGR (2026-2033)

• North America (Product Type, Animal Type, End User, Administration Route)
  • US
  • Canada
• Europe (Product Type, Animal Type, End User, Administration Route)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Animal Type, End User, Administration Route)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Animal Type, End User, Administration Route)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Animal Type, End User, Administration Route)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Zoetis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cegelec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neogen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dechra Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IDEXX Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parnell
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agrekko
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer CropScience
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivium Veterinary Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Market Player 20
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations